Novartis Option Fund intends to acquire a minority stake in Avila Therapeutics Inc

US - Novartis Option Fund, a unit of Novartis AG's Novartis Venture Fund subsidiary, was granted an option to acquire an undisclosed minority stake in Avila Therapeutics Inc, a Waltham-based biotechnology company, for up to USD ### mil in…

Deal Information

Credit & Investment Research

Market Research

News

Novartis AG (parent of Novartis Option Fund) Mergers & Acquisitions

Novartis AG acquires Zhejiang Tianyuan Bio-pharm Co (pending) (11/4/2009 12:00:00 AM)

Novartis AG acquires Ebewe Pharma GmbH-Specialty from Ebewe Pharma GmbH (9/24/2009 12:00:00 AM)

Novartis Pharma AG acquires BTG Plc-HySolv Tech from BTG PLC (8/28/2009 12:00:00 AM)

Novartis AG acquires a minority stake in Novartis India Ltd (6/25/2009 12:00:00 AM)

Novartis AG acquires Mipharm SpA-Branches(2) from Mipharm SpA (6/9/2009 12:00:00 AM)

Novartis AG intends to acquire Elixir Pharmaceuticals Inc (5/19/2009 12:00:00 AM)

Novartis AG is rumored to be planning to acquire Cubist Pharmaceuticals Inc (4/3/2009 12:00:00 AM)

Novartis AG acquires Nektar Therapeutics-Pulmonary from Nektar Therapeutics (12/31/2008 12:00:00 AM)

Novartis AG acquires Protez Pharmaceuticals Inc (7/17/2008 12:00:00 AM)

Novartis AG intends to purchase remaining interest in Speedel Holding AG (7/10/2008 12:00:00 AM)